CIK 0001590877
- Non-accelerated filer
- Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 471851754
- Phone
- +1 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- 4 Shares withheld for taxes Chief Financial Officer gave up 4,901 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Strategy & Legal Officer gave up 4,699 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 4,701 shares (to pay taxes)
- 4 Grant or award Director acquired 7,768 shares (grant or award)
- 4 Grant or award Director acquired 7,768 shares (grant or award)
- 4 Grant or award Director acquired 7,768 shares (grant or award)
- 4 Grant or award Director acquired 7,768 shares (grant or award)
- 4 Grant or award Director acquired 7,768 shares (grant or award)
- 4 Grant or award Director acquired 7,768 shares (grant or award)
- 4 Grant or award Director acquired 7,768 shares (grant or award)
- 4 Grant or award Director acquired 7,768 shares (grant or award)
- 4 Grant or award Director acquired 7,768 shares (grant or award)
- 4 Planned sale Director sold 20,602 shares at $7.91 ($163,046)
- 4 Shares withheld for taxes Chief Legal Officer gave up 4,700 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 5,263 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 5,452 shares (to pay taxes)
- 4 Exercise or conversion Director acquired 30,752 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4/A Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Medical Officer gave up 13,891 shares (to pay taxes)
Page 3 of 22 · 435 filings